Dr. Morel was elected to the Board of Directors of West Pharmaceutical Services in March 2002 and appointed Chairman of the Board in March 2003. Since April 2002 he has served as President and Chief Executive Officer. West Pharmaceutical Services is a diversified global technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products.

Prior to his current position, Dr. Morel served as President and Chief Operating Officer of West. He was formerly President of the Drug Delivery Division from October 1999 to May 2001. From March 1998 to October 1999 Dr. Morel served as Group President of the Device Development and Contract Packaging businesses of West.

Dr. Morel joined West Pharmaceutical Services full time in November 1992 as Director of Research for the North American Health Care Division. In June, 1995 he was appointed to the position of Corporate Vice President, Scientific Services, responsible for managing West Pharmaceutical Services’ Global Research and Development, Quality Assurance and Regulatory Affairs functions.

From October 1988 through November 1992, Dr. Morel was Director of Research on the technical staff of Applied Research International, Inc., a non-profit foundation chartered to perform sponsored applied research and development. From April of 1987 through October of 1988, Dr. Morel was with the Research Center of the PneumoAbex Corporation. Upon completing his graduate education, Dr. Morel joined the Government Aerospace Systems Division of Harris Corporation where he served three years as a staff engineer and as group leader of materials engineering.

Dr. Morel has authored or co-authored over thirty publications dealing with metal matrix composites, space environment effects on materials, polymer mechanical behavior, and electron microscopy of organic materials. His research on advanced materials has been supported by The National Science Foundation, NASA, Office of Naval Research, DARPA, and private industry.

Due to his scientific and engineering contributions to spacecraft design and manufacturing, Dr. Morel was one of one hundred candidates selected from over five thousand civilian applicants by NASA’s Astronaut Office 1989 for training as a Mission Specialist. He has served on several NASA scientific advisory committees including the SPACECRAFT 2000 Workshop to prioritize spacecraft materials research efforts and the Space Station Metals/Alloys Solidification Furnace Design Team.

In December 2003 Dr. Morel was chosen as Executive of the Year by Rubber & Plastics News for his corporate leadership following the Kinston plant explosion and fire.

Dr. Morel currently serves as Vice Chair of the Board of Trustees of the Franklin Institute in Philadelphia where he also Chairs the Franklin Awards Committee and the Bower Awards for Science and Business Leadership. He also serves as Chair of the American Oncologic Hospital Foundation Board and is a Director of the Fox Chase Cancer Center of Temple University. He is a Trustee of Lafayette College and serves on the Cornell University Biomedical Engineering Advisory Committee. In 2010 he was recognized as a Distinguished Alumnus by the Cornell College of Engineering and in 2006 was elected a Fellow of the American Institute for Medical and Biologic Engineering.

Dr. Morel received his Ph.D. in 1984 from Cornell University in Materials Science with a minor in Veterinary Medicine. He received his MS from Cornell in 1983 and his BS in 1979 from Lafayette College. In 1997 he completed The Executive Program at the University of Virginia’s Darden School of Business.

Go back